Literature DB >> 12442235

Predicting a life-threatening disease and death among ambulance-transported patients with chest pain or other symptoms raising suspicion of an acute coronary syndrome.

Johan Herlitz1, Elisabeth Hansson, Eva Ringvall, Mia Starke, Björn W Karlson, Lisbeth Waagstein.   

Abstract

The purpose of this study was to evaluate the possibility to predict in the prehospital phase the occurrence of a life-threatening disease or death among ambulance transported patients with acute chest pain or other symptoms raising any suspicion of an acute coronary syndrome. All patients transported by ambulance during 3 months in the community of Göteborg because of symptoms raising any suspicion of an acute coronary syndrome were included in the study. In all, 930 transports (of 859 patients) fulfilled the inclusion criteria, of which 235 (25.3%) fulfilled the criteria for a life-threatening disease. The overall 30-day mortality was 8.8%, and the 1-year mortality was 18.0%. Independent predictors for a life-threatening disease were a low oxygen saturation on admission of the ambulance crew, patient being clammy on admission of the ambulance crew, a history of myocardial infarction and ST elevation and T-wave inversion on admission to the emergency department. Independent predictors for 30-day mortality were age greater than 70 years, symptoms of dyspnoea, a low oxygen saturation, hypotension and decreased consciousness on admission of the ambulance crew, and ST-depression on electrocardiogram (ECG) on admission to the emergency department. Predictors of 1 year mortality were age greater than 70 years, a history of myocardial infarction, symptoms of dyspnoea, a low oxygen saturation on admission of the ambulance crew and ST-depression, and no sinus rhythm on admission to the emergency department. Among patients with acute chest pain or other symptoms raising any suspicion of an acute coronary syndrome, factors associated with a life-threatening disease and death could be defined. Predictors for the risk of death during the first 30 days were age greater than 70 years, symptoms of dyspnoea, a low oxygen saturation, hypotension and decreased consciousness on admission of the ambulance crew, and ST-depression on ECG on admission to the emergency department. Copyright 2002, Elsevier Science (USA). All rights reserved.)

Entities:  

Mesh:

Year:  2002        PMID: 12442235     DOI: 10.1053/ajem.2002.35461

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  5 in total

1.  Factors associated with advanced cardiac care in prehospital chest pain patients.

Authors:  Adam Frisch; Kenneth J Heidle; Stephanie O Frisch; Ashar Ata; Brandon Kramer; Caroline Colleran; Jestin N Carlson
Journal:  Am J Emerg Med       Date:  2017-12-05       Impact factor: 2.469

2.  Low oxygen saturation and mortality in an adult cohort: the Tromsø study.

Authors:  Monica Linea Vold; Ulf Aasebø; Tom Wilsgaard; Hasse Melbye
Journal:  BMC Pulm Med       Date:  2015-02-12       Impact factor: 3.317

Review 3.  Nontraumatic hypotension and shock in the emergency department and the prehospital setting, prevalence, etiology, and mortality: a systematic review.

Authors:  Jon Gitz Holler; Camilla Nørgaard Bech; Daniel Pilsgaard Henriksen; Søren Mikkelsen; Court Pedersen; Annmarie Touborg Lassen
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

4.  Low oxygen saturation is associated with pre-hospital mortality among non-traumatic patients using emergency medical services: A national database of Thailand.

Authors:  Yuwares Sittichanbuncha; Sorrawit Savatmongkorngul; Puchong Jawroongrit; Kittisak Sawanyawisuth
Journal:  Turk J Emerg Med       Date:  2015-11-17

5.  Pre-hospital predictors of an adverse outcome among patients with dyspnoea as the main symptom assessed by pre-hospital emergency nurses - a retrospective observational study.

Authors:  Wivica Kauppi; Johan Herlitz; Thomas Karlsson; Carl Magnusson; Lina Palmér; Christer Axelsson
Journal:  BMC Emerg Med       Date:  2020-11-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.